|
QPS has supported gene therapy development since 2002, offering custom-built quantitation methods and precision bioanalysis for oligonucleotide therapeutics.
From PK and ADME, to immunogenicity and biodistribution, QPS scientists are ready to guide your oligonucleotide drug development with fully compliant data packages.
|